Aortic sclerosis echocardiography and ultrasound

Jump to navigation Jump to search

Aortic sclerosisMicrochapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating aortic sclerosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Aortic sclerosis echocardiography and ultrasound On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aortic sclerosis echocardiography and ultrasound

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aortic sclerosis echocardiography and ultrasound

CDC on Aortic sclerosis echocardiography and ultrasound

Aortic sclerosis echocardiography and ultrasound in the news

Blogs on Aortic sclerosis echocardiography and ultrasound

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Aortic sclerosis echocardiography and ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]

Overview

Aortic sclerosis is defined based on transthoracic echocardiographic findings which include focal valve thickening with associated increase in echogenicity.[1][2][3][4]

Echocardiographic Features

  • Focal areas of valve thickening with associated increase in echogenicity is the hallmark of aortic sclerosis, as opposed to diffuse thickening observed as a part of normal aging
  • Aortic side of the valve in the center of the valve cusp is commonly affected
  • Commissural areas are spared
  • Irregular leaflet thickening
  • Leaflet mobility is normal
  • Valvular hemodynamic parameters are normal with a jet velocity of less than 2.5 m per sec across the valve

References

  1. Freeman RV, Otto CM (2005). "Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies". Circulation. 111 (24): 3316–26. doi:10.1161/CIRCULATIONAHA.104.486738. PMID 15967862. Retrieved 2012-04-10. Unknown parameter |month= ignored (help)
  2. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS (1999). "Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly". The New England Journal of Medicine. 341 (3): 142–7. doi:10.1056/NEJM199907153410302. PMID 10403851. Retrieved 2012-04-10. Unknown parameter |month= ignored (help)
  3. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM (1997). "Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study". Journal of the American College of Cardiology. 29 (3): 630–4. PMID 9060903. Retrieved 2012-04-10. Unknown parameter |month= ignored (help)
  4. Gharacholou SM, Karon BL, Shub C, Pellikka PA (2011). "Aortic valve sclerosis and clinical outcomes: moving toward a definition". The American Journal of Medicine. 124 (2): 103–10. doi:10.1016/j.amjmed.2010.10.012. PMID 21295189. Retrieved 2012-04-10. Unknown parameter |month= ignored (help)

Template:WH Template:WS